Translate page

GoldmanPrize medal RGB reduc

November 2018 - The Foundation is celebrating its 10th anniversary next year. This also marks the tenth anniversary of our tradition to recognise and reward personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML around the world. It all started with the first iCMLf Rowley Prize awarded to Professor Brian Druker in 2009. This was followed by the introduction of the iCMLf Goldman Prize in 2014 and the iCMLf Prize in 2015.

We will continue this tradition next year. You are now welcome to nominate a colleague, or mentor for one of the 2019 prizes. Who would you like to see awarded the iCMLf prizes next year?

Annual Report 20172018Proven programs and new visions -
iCMLf Annual Report 2017/2018

October 2018 - Over the past 10 years, we have worked hand in hand with our partners and experts to complete the mission of the iCMLf to improve the situation of patients with CML worldwide. In this Annual Report we would like to share with you what we have already achieved and our vision for the years to come. 

The Annual Report 2017/2018 features the iCMLf activities from Sept. 1st 2017 to August 31st 2018. 
Read more on the highlights in the iCMLf Annual Report 2017/2018 here.

iCMLf Newsletter I 2018June 2018 - We are delighted to present to you the new edition of the iCMLf Newsletter that features the Foundation's activities and programs over the last six months. 
Download the pdf file here
Contents overview:

  • News from the iCMLf - supporters and experts from the Foundation
  • iCMLf progam update - news from our core programs and activities
  • Summary of key publications - 5-year results from the phase II PACE trial
  • iCMLf educational services - new interactive eLearning tool for CML

May 2018 - The iCMLf Diagnosis and Testing Program offers seeding grants to hematology institutions in emerging economic regions. The aim of the program is to facilitate the diagnosis, testing and long-term disease monitoring of CML patients in emerging economic regions where it is either limited, or not currently available.

Over six years the iCMLf have awarded 48 grants to enable CML diagnostics to be expanded and enhanced at a local level. This gives both physicians and patients the knowledge to make meaningful decisions on treatment. In 2018 the Foundation will offer 10 grants with funding of up to $10,000.

Applications will close on the 30th of July 2018. Proposals are welcome to arlene@cml-foundation.org.
Read more for further information on how to apply.

April 2018 - We are delighted to announce new members of the iCMLf board of Directors and Scientific Advisory Committee. The iCMLf was formed to assist the CML scientific community by leading haematologists in the field. As such, the trustees and advisors of the Foundation are all key CML experts. These people are critical to the strength of the iCMLf giving most generously of their time and expertise. In 2018 we welcome 2 new Directors and 4 new advisors to the iCMLf.

David Ross

April 2018 - There are five new presentations on various aspects of CML management. All are recordings of leading expert presentations during a key-opinion leaders' meeting in Adelaide (Australia).